Big news from China and the FDA is a serious tailwind! 📈 The stock's been coiling between $6.12-$6.38, with RSI a neutral ~50. The 9-period EMA just crossed *above* the 21-period, signaling a fresh uptrend. This looks like a coiled spring with positive catalysts. BUY the momentum. #MASHwave

Denifanstat's clinical wins are creating serious buzz! 📈 But the stock just got smacked down - RSI is oversold at 37 and that 1.5M volume spike screams panic selling. This looks like a classic "buy the rumor, sell the news" flushout. With multiple catalysts ahead, I'm calling this a BUY-the-dip opportunity. The fear is overdone. #BiotechBounce

The news firehose is on full blast! 🔥 With a packed conference schedule and key 2026 readouts looming, the narrative is pure momentum. Technically, it's cooling off from an overbought pop, with the RSI now a neutral ~50. This looks like a classic "buy the rumor, buy the dip" setup before the next catalyst. Strong BUY. #MASHMomentum

The news avalanche is pure rocket fuel! 🚀 Phase 3 acne success, MASH momentum, and bullish analyst upgrades are the real story. The technicals are just catching up—RSI is neutral and WMAs are starting to curl, suggesting the tide is turning after that nasty plunge. This coiled spring is ready to pop. All signs point to a decisive BUY. #BiotechBounce